[Evaluation of a new intravenous device]

Area of Science:

• Clinical Pharmacy
• Healthcare Technology
• Drug Preparation

Context:

• Intravenous (IV) admixture preparation faces challenges including microbial contamination, human error, and high costs.
• Existing methods require multiple manipulations, increasing the risk of contamination and wastage.
• The development of novel systems is crucial for improving safety and efficiency in drug preparation.

Purpose:

• To evaluate the Vialink system, a novel device designed to improve the safety and efficiency of IV admixture preparation.
• To assess the Vialink system's impact on sterility, preparation time, cost-effectiveness, and suitability for routine hospital use.
• To determine if the Vialink system offers a viable solution to common problems in clinical IV admixture preparation.

Summary:

• The Vialink system minimizes contamination risk through a single-penetration design, ensuring enhanced sterility during IV admixture preparation.
• Dilution occurs immediately before administration, reducing wastage of unused admixtures and allowing for a visual check of contents.
• The system was found suitable for 58.2% of hospital-prepared IV admixtures, demonstrating practical applicability.

Impact:

• The Vialink system offers substantial savings in preparation time and expense, optimizing resource allocation.
• It improves the quality of pharmaceutical services provided to patients by healthcare teams and hospital pharmacists.
• Implementation of the Vialink system can lead to significant budget and manpower savings within healthcare institutions.